Perioperative Specimen Imaging Using High-resolution 18F-FDG-PET-CT During Thoracic Surgery: a Pilot Study
Launched by UNIVERSITY HOSPITAL, GHENT · Jan 11, 2023
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new imaging technique that helps doctors during lung surgery. The study is testing a special type of scan called high-resolution PET-CT, which can quickly show the doctor whether they have removed enough cancerous tissue and if any nearby lymph nodes are affected. This imaging can be done right in the operating room and takes less than 10 minutes per sample, allowing the surgeon to make important decisions during the procedure.
To join this study, participants must be at least 18 years old and have suspected or confirmed lung cancer that requires surgery. They should also be able to follow the study's guidelines and give their consent to participate. However, people with certain medical conditions or infections, those who are pregnant or breastfeeding, or those who have recently been in other studies involving radiation may not be eligible. Participants can expect to receive advanced imaging during their surgery, which aims to improve surgical outcomes and ensure the best care possible.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient is 18 years of age or older.
- • Patient with suspected or confirmed lung malignancies
- • Patient is indicated to undergo thoracic surgery.
- • Patient is estimated to be compliant for study participation by the investigator.
- • Patient has freely given his/her informed consent to participate in this study.
- Exclusion Criteria:
- • Patient has general or local contra-indications for thoracic surgery.
- • Patient has active infection.
- • Blood glucose level over 200 mg/dL on the day of surgery.
- • Pregnancy or lactation.
- • Patient participated in other clinical studies with radiation exposure of more than 1 mSv in the past year
About University Hospital, Ghent
University Hospital Ghent is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. Located in Ghent, Belgium, the hospital is affiliated with Ghent University, fostering a collaborative environment that integrates cutting-edge medical research with high-quality patient care. With a diverse range of specialized departments and a dedicated team of researchers and clinicians, University Hospital Ghent is at the forefront of developing new therapies and improving treatment protocols, aiming to enhance patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ghent, , Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials